loading page

On admission hemoglobin and albumin; two novel factors associated with thrombosis in COVID-19 pneumonia
  • +10
  • Somayeh Sadeghi,
  • Peiman Nasri,
  • Maryam Nasirian,
  • Maryam Sadat Mirenayat,
  • Elaheh Nasri,
  • Arash Toghyani,
  • Huriyeh Hashemi,
  • Hamed Fakhim,
  • Ali Safaei,
  • Elham Raofi,
  • Koorosh Nemati,
  • Mohammadsaeid Khaksar,
  • Elaheh Keivany
Somayeh Sadeghi
Acquired Immunodeficiency Research Center, Al-Zahra Hospital, Isfahan University of Medical Sciences, Isfahan, Iran
Author Profile
Peiman Nasri
Metabolic Liver Disease Research Center, Imam Hosein Hospital, Isfahan University of Medical Sciences, Isfahan, Iran
Author Profile
Maryam Nasirian
Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
Author Profile
Maryam Sadat Mirenayat
Chronic Respiratory Diseases Research Center (CRDRC), National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Isfahan, Iran.
Author Profile
Elaheh Nasri
Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
Author Profile
Arash Toghyani
School of Medicine, Isfahan University of Medical sciences, Isfahan, Iran
Author Profile
Huriyeh Hashemi
Department of internal medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Author Profile
Hamed Fakhim
Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
Author Profile
Ali Safaei
Isfahan Cardiovascular Research Institute, Cardiovascular Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Author Profile
Elham Raofi
Department of internal medicine, Isfahan University of Medical Sciences, Isfahan, Iran
Author Profile
Koorosh Nemati
Department of Clinical Toxicology, School of Medicine, Isfahan University of Medical sciences, Isfahan, Iran.
Author Profile
Mohammadsaeid Khaksar
Department of internal medicine, Isfahan University of Medical Sciences, Isfahan, Iran
Author Profile
Elaheh Keivany
Department of internal medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Corresponding Author:e.keivany@gmail.com

Author Profile

Abstract

Introduction: The unrelenting storm of coronavirus disease (COVID-19) since late 2019 has turned into a crucial health matter of the globe. There is increasing evidence in terms of a hypercoagulable state by this infection. Therefore, the current study aims to clarify the association between thromboembolic events in COVID-19 and the patient, the infection, and in-hospital related characteristics. Methods: The current case-control study has been conducted on 243 COVID-19 pneumonia patients (83 cases with thrombotic events and 160 controls without thrombosis) in 2020. The thrombotic events included deep venous thrombosis (DVT) (n=9), pulmonary thromboembolism (PTE) (n=48), acute myocardial infarction (AMI) (n=17), cerebrovascular accidents (CVA) (n=4) and arterial thrombosis (n=5). On admission, hemodynamic parameters, on admission laboratory assessments, mobility during hospitalization, type of oxygenation, intensive care unit (ICU) admission requirement, duration of ICU and hospital stay were recorded in the checklist. Results: According to logistic regression assessment, on admission O2 saturation (OR: 0.97, 95%CI: 0.94-0.99), hemoglobin level (OR: 0.87, 95%CI: 0.77-0.97) and albumin level (OR: 0.53, 95%CI: 0.3-0.86) were independently correlated with thrombosis due to COVID-19. Other factors, including demographic, infection severity, laboratory and in-hospital characteristics, were not significantly associated with thrombotic events. Conclusion: Based on this study’s findings, hemoglobin and albumin levels were the independent factors associated with the thrombotic events in COVID-19 patients.